Differential brain region-specific expression of MeCP2 and BDNF in Rett Syndrome patients: a distinct grey-white matter variation
- 1 December 2020
- journal article
- research article
- Published by Wiley in Neuropathology and Applied Neurobiology
- Vol. 46 (7), 735-750
- https://doi.org/10.1111/nan.12619
Abstract
Introduction and objectives Rett Syndrome (RTT) is a neurodevelopmental disorder caused by Methyl CpG Binding Protein 2 (MECP2) gene mutations. Previous studies of MeCP2 in the human brain showed variable and inconsistent mosaic-pattern immunolabelling, which has been interpreted as a reflection of activation-state variability. We aimed to study post mortem MeCP2 and BDNF (MeCP2 target) degradation and brain region-specific detection in relation to RTT pathophysiology. Methods We investigated MeCP2 and BDNF stabilities in non-RTT human brains by immunohistochemical labelling and compared them in three brain regions of RTT and controls. Results In surgically excised samples of human hippocampus and cerebellum, MeCP2 was universally detected. There was no significantly obvious difference between males and females. However, post mortem delay in autopsy samples had substantial influence on MeCP2 detection. Immunohistochemistry studies in RTT patients showed lower MeCP2 detection in glial cells of the white matter. Glial fibrillary acidic protein (GFAP) expression was also reduced in RTT brain samples without obvious change in myelin basic protein (MBP). Neurons did not show any noticeable decrease in MeCP2 detection. BDNF immunohistochemical detection showed an astroglial/endothelial pattern without noticeable difference between RTT and controls. Conclusions Our findings indicate that MeCP2 protein is widely expressed in mature human brain cells at all ages. However, our data points towards a possible white matter abnormality in RTT and highlights the importance of studying human RTT brain tissues in parallel with research on animal and cell models of RTT.Keywords
Funding Information
- International Rett Syndrome Foundation (3212)
This publication has 84 references indexed in Scilit:
- MeCP2 modulates gene expression pathways in astrocytesMolecular Autism, 2013
- Novel MeCP2 Isoform-Specific Antibody Reveals the Endogenous MeCP2E1 Expression in Murine Brain, Primary Neurons and AstrocytesPLOS ONE, 2012
- Comparative Effect of Treadmill Exercise on Mature BDNF Production in Control versus Stroke RatsPLOS ONE, 2012
- Linking Epigenetics to Human Disease and Rett Syndrome: The Emerging Novel and Challenging Concepts in MeCP2 ResearchNeural Plasticity, 2012
- Rett syndrome: Revised diagnostic criteria and nomenclatureAnnals of Neurology, 2010
- Rett syndrome diagnostic criteria: Lessons from the Natural History StudyAnnals of Neurology, 2010
- MECP2 Isoform-Specific Vectors with Regulated Expression for Rett Syndrome Gene TherapyPLOS ONE, 2009
- Regulated Release of BDNF by Cortical Oligodendrocytes is Mediated Through Metabotropic Glutamate Receptors and the PLC PathwayASN Neuro, 2009
- Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neuronsProceedings of the National Academy of Sciences of the United States of America, 2008
- Comprehensive diagnosis of Rett's syndrome relying on genetic, epigenetic and expression evidence of deficiency of the methyl-CpG-binding protein 2 gene: study of a cohort of Israeli patientsJournal of Medical Genetics, 2006